Publicaciones en colaboración con investigadores/as de Thomas Jefferson University (26)

2024

  1. Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

    Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97

2023

  1. Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1

    Journal of Thoracic Oncology, Vol. 18, Núm. 8, pp. 1055-1069

2022

  1. Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort

    The Lancet Rheumatology, Vol. 4, Núm. 11, pp. e785-e794

2020

  1. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

    The Lancet HIV, Vol. 7, Núm. 1, pp. e16-e26

  2. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

    Arthritis research & therapy, Vol. 22, Núm. 1, pp. 257

  3. Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study

    Rheumatology (United Kingdom), Vol. 59, Núm. 7, pp. 1684-1694

2019

  1. The role of atrial fibrillation in the short-term outcomes of patients with acute heart failure

    Clinical Research in Cardiology, Vol. 108, Núm. 6, pp. 622-633

2018

  1. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

    The Lancet HIV, Vol. 5, Núm. 5, pp. e211-e220

  2. Effects on short term outcome of non-invasive ventilation use in the emergency department to treat patients with acute heart failure: A propensity score-based analysis of the EAHFE Registry

    European Journal of Internal Medicine, Vol. 53, pp. 45-51

  3. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204

  4. Pemetrexed Continuation Maintenance Phase 3 Trials in Nonsquamous, Non–Small-Cell Lung Cancer: Focus on 2-Year Overall Survival and Continuum of Care

    Clinical Lung Cancer, Vol. 19, Núm. 6, pp. e823-e830

  5. The BRONCH-AHF study: effects on short-term outcome of nebulized bronchodilators in emergency department patients diagnosed with acute heart failure

    European Journal of Heart Failure

2017

  1. Cardiopoietic cell therapy for advanced ischaemic heart failure: Results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

    European Heart Journal, Vol. 38, Núm. 9, pp. 648-660

  2. Disposition of emergency department patients diagnosed with acute heart failure: An international emergency medicine perspective

    European Journal of Emergency Medicine, Vol. 24, Núm. 1, pp. 2-12

  3. How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials

    Annals of Oncology, Vol. 28, Núm. 9, pp. 2077-2085

  4. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry

    Chest, Vol. 152, Núm. 4, pp. 821-832

  5. Update of EULAR recommendations for the treatment of systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 8, pp. 1327-1339

2016

  1. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 1, pp. 163-169

2014

  1. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672

2013

  1. 2013 classification criteria for systemic sclerosis: An American college of rheumatology/European league against rheumatism collaborative initiative

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 11, pp. 1747-1755